Qiming Venture Partners is an institutional investor (Conventional VCs) founded in 2006 and headquartered in Shanghai, China. Qiming Venture Partners is a leading China venture capital firm founded in 2006. Since inception, the firm has been in touch with tens of thousands of founding teams. On average, one out of 30 companies receives funding. Seventy percent of investments are in Series A or Series B, and many portfolio companies become industry leaders in less than seven years. The firm invests across Technology and Healthcare sectors. Venture capital firm investing in multiple sectors. HK), Broncus (SEHK:2216), CANbridge Pharmaceuticals (SEHK:1228), Cootek (NYSE:CTK), Connect Biopharma (Nasdaq:CNTB), ChinaCache (Nasdaq:CCIH), eHi (NYSE:EHIC), Fanli (SHSE:600228), Forgame (00484. HK), Apollomics (NASDAQ:APLM).

Stage

Early Stage, Growth, Series A (majority), Early Stage, Growth, Series A (majority)

HQ

Shanghai, china

Founded

2006

Website

https://www.qimingvc.com/

LinkedIn

https://linkedin.com/company/qiming-venture-partners

Twitter

http://twitter.com/qimingvc

What they look for

Entrepreneur-friendly; preferred investor for top entrepreneurs / founding teams

Preparing to pitch Qiming Venture Partners?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.